South China to receive innovative new proton therapy facility
Proton therapy systems provider Mevion Medical Systems will supply Jinshazhou Hospital of Guangzhou University of Chinese Medicine with a MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning
Proton therapy is an advanced form of radiation therapy that reduces unnecessary radiation to healthy tissue and prevents complications and secondary cancers. Mevion’s leading HYPERSCAN Pencil Beam Scanning technology further enhances these benefits with a faster and sharper dose delivery, which can be collimated layer-by-layer to deliver a more precise and conformal dose to the tumour.
The new system will be incorporated into the Hospital’s International Cancer Centre in Guangzhou – making it the first compact proton therapy system in the Guangdong-Hong Kong-Macau Greater Bay Area.
Led by Yang Wang, Vice-President of Jinshazhou Hospital and Director of the International Cancer Center, the International Cancer Center is a joint effort between Jinshazhou Hospital and the ICON Group, Australia’s leading cancer care service provider. The University of Wollongong in Australia will also collaborate with the Center to provide medical physics training and education.
“We are pleased to be partnering with Mevion to make proton therapy available to benefit cancer patients in South China,” said Wensheng Liu, President of Jinshazhou Hospital. “MEVION S250i system is the most advanced proton therapy system available today and represents the best overall proton therapy solution. Its addition will position Jinshazhou Hospital as a world-class radiation therapy centre. We look forward to elevating our cancer treatment, research capabilities, and medical education to the next level with protons.”
The new facility is expected to begin treatment in 2021.